Open-Label, Single-Arm Phase II Study of Pembrolizumab Monotherapy as First-Line Therapy in Patients With Advanced Clear Cell Renal Cell Carcinoma

JOURNAL ARTICLE published 20 March 2021 in Journal of Clinical Oncology

Authors: David F. McDermott | Jae-Lyun Lee | Georg A. Bjarnason | James M. G. Larkin | Rustem A. Gafanov | Mark D. Kochenderfer | Niels Viggo Jensen | Frede Donskov | Jahangeer Malik | Alexandr Poprach | Scott S. Tykodi | Teresa Alonso-Gordoa | Daniel C. Cho | Poul F. Geertsen | Miguel Angel Climent Duran | Christopher DiSimone | Rachel Kloss Silverman | Rodolfo F. Perini | Charles Schloss | Michael B. Atkins